Aethlon Medical, Inc. (AEMD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
11555 Sorrento Valley Road
San Diego, CA 92121
United States of America (the)
Phone
619 941 0360
Sector
Healthcare
Industry
Medical - Devices
Employees
14
First IPO Date
March 04, 1999
| Name | Title | Pay | Year Born |
| James Frakes | Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Secretary & Director | 500,000 | 1957 |
| Steven LaRosa | Chief Medical Officer | 480,000 | 1968 |
| Michele Bombardiere | Vice President & Controller | 0 | N/A |
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. Furthermore, Aethlon Medical maintains a collaborative partnership with the University of Pittsburgh Medical Center's Hillman Cancer Center, conducting studies pertinent to head and neck cancer. Established in 1999, the company is headquartered in San Diego, California.